medigraphic.com
ISSN 2007-3194 (Print)
Órgano de difusión oficial del Instituto Materno Infantil del Estado de México

2010, Number 2

<< Back Next >>

Arch Inv Mat Inf 2010; 2 (2)

Riesgo de dislipidemia en pacientes que han sufrido preeclampsia

Herrera-Villalobos JE, Garay SG, Adaya LE, Camacho BR, Garduño AA, Nava DPM

Language: Spanish
References: 12
Page: 67-70
PDF size: 138.10 Kb.


ABSTRACT

Background: Dyslipidemia is the alteration of blood lipid levels, either by an elevation of cholesterol or triglycerides. This lipid disorder is considered major vascular risk factors that predispose certain diseases such as preeclampsia. Objective: To determine the behavior of lipids in women has one year after having presented preeclampsia. Methods: This is a cross-sectional study; we evaluated 60 women to twelve months of obstetrical care and who had preeclampsia syndrome. Each patient underwent a questionnaire with demographic data and personal history. Anthropometric data were measured, blood pressure and blood sample was obtained in fasting for the measurement of biochemical variables (lipid profile). Results: The signs and symptoms (headache, tinnitus, epigastric pain, right upper quadrant pain, vomiting, hyper, spontaneous ecchymosis) disappeared, only two patients report occasional headache as the service were channeled to rule out neurological a pattern of migraines. In relation to signs specifically blood pressure five of them were classified as chronic hypertension. The anthropometric parameters, more than eighty percent are with a body mass index of 33.3. In relation to laboratory studies, as the cornerstone of this study, we have that the cholesterol and triglyceride levels remained elevated to a year after obstetric and biochemical parameters of glucose and uric acid were within normal parameters. Conclusions: The frequency of dyslipidemia in patients with a history of severe preeclampsia than one year after childbirth was 10%. The distribution of fat and the blood pressure was altered a year after the obstetric event, the behavior of Lipid (cholesterol, triglycerides, LDL and HDL) are factors that change over time and could determine the medium-term metabolic syndrome.


REFERENCES

  1. Briones-Garduño JC, Herrera-Villalobos JE, Vázquez-de Anda GF, Rodríguez-Roldán M et al. Presencia del equinocito en el síndrome de preeclampsia-eclampsia ¿Manifestación subclínica del síndrome? Cir Ciruj 2003; 71 (6): 455-459.

  2. Hubel CA, Powers RW, Snaedal S, Gammill HS, Ness RB, Roberts JM, Arngrímsson R. C-reactive protein is elevated 30 years after eclamptic pregnancy. Hypertension 2008 Jun; 51(6): 1499-505. Epub 2008 Apr 14.

  3. Stewart FM, Freeman DJ, Ramsay JE, Greer IA, Caslake M, Ferrell WR. Longitudinal assessment of maternal endothelial function and markers of inflammation and placental function throughout pregnancy in lean and obese mothers. J Clin Endocrinol Metab 2007 Mar; 92 (3): 969-75. Epub 2006 Dec 27.

  4. Kaaja RJ, Greer IA. Manifestations of chronic disease during pregnancy. JAMA 2005 Dec 7; 294 (21): 2751-7. Review.

  5. Adiga U, D’Sousa V, Kamath A, Mangalore N. Antioxidant Activity and Lipid Peroxidation in Preeclampsia; Journal of the Chinese Medical Association 2007 Oct; 70 (10): 435-438.

  6. Cruz HJ, Hernández GP, Yanes QM, Isla VA. Factores de riesgo de preeclampsia: enfoque inmunoendocrino. Parte I. Rev Cubana Med Gen Integr [online]. 2007, vol. 23, n.4.

  7. Cruz HJ, Hernández GP, Yanes QM, Isla VA. Factores de riesgo de preeclampsia: enfoque inmunoendocrino. Parte II. Rev Cubana Med Gen Integr [online]. 2008; vol. 24, n.1.

  8. Reyna-Villasmil E, Prieto-Franchi M, Torres-Montilla M et al. Alteración en el metabolismo de los carbohidratos y lípidos en mujeres que han sufrido preeclampsia. Rev Obstet Ginecol Venez 2002 Jun; 62 (2): 97-102. ISSN 0048-7732.

  9. Pizano-Zarate ML et al. Papel de la preeclampsia en la evolución clínica, antropométrica y bioquímica en el primer año postparto. Perinatol Reprod Hum. 2006; 20(4), pp. 52-59.

  10. Rubio R, Hamilton A, Miranda G et al. Lipoproteínas e hipertensión inducida por el embarazo. Gac Méd Caracas 2003 jul; vol.111, No. 3, pp. 197-2005. ISSN 0367-4762.

  11. Peralta-Pedrero ML, Guzmán-Ibarra MA, Cruz-Avelar A, Basavilvazo-Rodríguez MA, Sánchez-Ambriz S, Martínez-García MC. Utilidad para establecer diagnóstico y severidad de los síntomas y signos más frecuentes en la paciente preeclámptica. Gac Med Mex 2004; 140 (5): 513-518.

  12. Moreno Z, Sánchez S, Piña F, Reyes A, Williams M. Obesidad pregestacional como factor de riesgo asociado a preeclampsia. Anales de la Facultad de Medicina 2003; 64 (2): pp.101-106




2020     |     www.medigraphic.com